Gufic Biosciences

Price chart

Previous close

₹436.30

Open

₹438.45

Day high

₹467.00

Day low

₹436.40

Listed on NSE since 19 October 2004.

Market value

₹4,375.33 Cr

P/E (trailing)

59.60

EPS (trailing)

₹7.32

Price to book

6.58

Dividend yield

0.02%

Debt to equity

0.61

Profit margin

7.5%

Beta

-0.02

Volume today

3.12 L

Average volume

1.08 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Gufic Biosciences’s results filed with NSE, consolidated (the whole group). Net profit is the share of Gufic Biosciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Gufic Biosciences’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. Further, it engages in contract and bulk drug manufacturing business. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

1,607

Company website · Profile: Yahoo Finance

No headlines name Gufic Biosciences in the last day or two.

• Dividend - Re 0.10 Per Share

  Dividend · ex-date 28 August 2026

• Dividend - Re 0.10 Per Share

  Dividend · ex-date 22 September 2025

• Annual General Meetingdividend - Re 0.10 Per Share

  Dividend · ex-date 17 September 2024

• Annual General Meeting/Dividend - Re 0.10 Per Share

  Dividend · ex-date 21 September 2023

• Annual General Meeting/Dividend - Rs 0.10 Per Sh

  Dividend · ex-date 24 August 2022

• Annual General Meeting/Dividend - Rs 0.10 Per Share

  Dividend · ex-date 9 September 2021

• Annual General Meeting/Dividend - Rs 0.05 Per Share

  Dividend · ex-date 3 November 2020

• Annual General Meeting/Dividend - Rs 0.05 Per Equity Share

  Dividend · ex-date 20 September 2019

Source: NSE. Latest first, 8 of 20.